tirzepatide vs. semaglutide Semaglutide: Which GLP-1 Medication Is Right for You? Tirzepatide vs. semaglutide: Study compares

J Matern Fetal Neonatal Med (2012) 25(3):20721

In one study, three healthy male subjects receiving daily subcutaneous MT-II dosed at 0.01 mg/kg variously reported the following side effects during the two-week course of administration [1]: Moderate to severe nausea Repetitive yawning and stretching Spontaneous erections Fatigue Drowsiness Additional studies have linked MT-II administration with the darkening of pre-existing naevi (moles) and the development of new ones

IMPORTANT NOTE: Your medication should be red, as it is mixed with B12, please do not hesitate to reach out to support with further questions

Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin